-

FUJIFILM Sonosite Launches Sonosite MT, a Next-Generation Clamshell Ultrasound System Designed for Durability, Imaging Excellence, and Enhanced Mobility

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) solutions, today announced the launch of Sonosite MT, the latest evolution in its line of portable ultrasound systems. Continuing Sonosite’s commitment to creating the most durable, reliable, and easy-to-use ultrasound technology with an education-first approach, Sonosite MT joins the renowned Sonosite PX, Sonosite LX, and Sonosite ST systems to advance clinical imaging across healthcare environments.

Designed as a “Grab and Go” clamshell form factor, Sonosite MT is engineered for seamless use both on and off the stand, offering clinicians superb mobility without compromising functionality. Featuring an intuitive all-touch user interface, a clinical monitor and control panel, this system delivers a familiar user experience that minimizes workflow disruption and promotes clinician adoption.

“At FUJIFILM Sonosite, our mission is to empower clinicians with ultrasound systems that perform reliably in the most demanding clinical settings. Sonosite MT exemplifies this mission by integrating our core product pillars: durability, reliability, and ease of use,” said Richard Fabian, president and chief executive officer of FUJIFILM Sonosite, Inc. “This new system continues our journey of excellence, providing a portable ultrasound platform that supports both clinical confidence and operational efficiency.”

Key features of the Sonosite MT include:

  • Durable Design: Engineered to withstand the rigors of the clinical environment, ensuring uptime and dependable performance
  • Excellent Imaging: Delivers clear, high-resolution images to support accurate diagnosis across diverse patient populations
  • Enhanced Mobility: Lightweight and compact, enabling quick transport and use in various care settings
  • Intuitive All-Touch User Interface: Seamless touchscreen control with a user experience harmonized with the FFSS portfolio, facilitating ease of training and adoption
  • Risk Management and Infection Control: Featuring a buttonless monitor and control panel design that can be easily cleaned and disinfected.
  • Medical Informatics Interoperability: Integrated with Synapse Synchronicity™ workflow manager to streamline clinical operations and data management

Sonosite MT reaffirms FUJIFILM Sonosite’s dedication to innovation and excellence in point-of-care ultrasound, providing healthcare professionals with reliable tools to improve patient outcomes.

To learn more about the Sonosite MT visit www.sonosite.com/products/sonosite-mt.

About Fujifilm

FUJIFILM Sonosite, Inc. is the innovator and world leader in bedside and point-of-care ultrasound, and an industry leader in ultra-high frequency micro-ultrasound technology. Headquartered near Seattle, the company is represented by a global distribution network in over 100 countries. Sonosite’s portable, compact systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. For more information, please visit www.sonosite.com.

FUJIFILM Holdings Corporation, headquartered in Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver innovative products and services across the globe through the four key business segments of healthcare, electronics, business innovation, and imaging with over 70,000 employees. Guided and united by our Group Purpose of “giving our world more smiles,” we address social challenges and create a positive impact on society through our products, services, and business operations. Under its medium-term management plan, VISION2030, which ends in FY2030, we aspire to continue our evolution into a company that creates value and smiles for various stakeholders as a collection of global leading businesses and achieve a global revenue of 4 trillion yen. For more information, please visit: www.fujifilmholdings.com.

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

FUJIFILM


Release Versions

Contacts

Marissa Confredo
914-343-4761
Marissa.confredo@fujifilm.com

More News From FUJIFILM

FUJIFILM Sonosite Introduces PIV Assist, an AI-Powered Ultrasound Feature to Support Peripheral IV Procedures

BOTHELL, Wash.--(BUSINESS WIRE)--FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) solutions, announces the launch of PIV Assist, a new AI-powered feature designed to assist clinicians in planning peripheral intravenous (PIV) access procedures. The feature will be available on Sonosite LX, Sonosite PX, and Sonosite ST ultrasound systems. "Peripheral IV procedures are among the most common performed on patients, and growing evidence supports ultrasound-guided insertion...

Fujifilm to Unveil Synapse One, a Comprehensive Enterprise Imaging and Informatics Solution Tailored to Meet the Demands of Outpatient Imaging Centers, at RSNA 2025

LEXINGTON, Mass.--(BUSINESS WIRE)--FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, today announced the launch of Synapse One, a comprehensive, tailor-made workflow solution designed for unique outpatient imaging needs, in North America*. This all-inclusive enterprise imaging solution enables providers to address everything from patient engagement portal, self-scheduling of exams, RIS (Radiology Information System), advanced schedulin...

Fujifilm Launches Bioethics Advisory Committee to Guide Ethical Decision-Making Across Life Sciences and Healthcare Businesses in the Americas

VALHALLA, N.Y.--(BUSINESS WIRE)--FUJIFILM Holdings America Corporation, the regional headquarters of FUJIFILM Corporation -- a global leader in life sciences and healthcare -- today announced the formation of its Bioethics Advisory Committee, a cross-disciplinary body established to provide independent recommendations, governance guidance, and accountability mechanisms to Fujifilm’s life sciences and healthcare subsidiaries. The Committee will advise on complex ethical considerations that arise...
Back to Newsroom